APP and Alzheimer disease: In a neurodegenerative context characterized by brain iron accumulation and neuroinflammation, such as for Alzheimer’s disease (AD), hepcidin derived from astrocytes can ameliorate AD symptoms of APP/PS1 transgenic mice, attenuating iron deposition, with consequent alleviated oxidative stress and neuronal cell death [31,32].